Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.9B
| $2.16M | ﹤0.01% |
32,760
+1,697
| +5% | +$116K |
|
5127
Magna International
MGA
$18.6B
| $2.16M | ﹤0.01% |
40,407
+36,435
| +917% | +$2.11M |
|
|
CHCT
5128
Community Healthcare Trust
CHCT
$436M
| $2.16M | ﹤0.01% |
59,139
-51,536
| -47% | -$2.01M |
|
5129
PUT
Fulgent Genetics
FLGT
$513M
| $2.16M | ﹤0.01% |
69,300
+600
| +0.9% | +$19.3K |
|
5130
PUT
Trex
TREX
$5.06B
| $2.16M | ﹤0.01% |
44,400
-280,300
| -86% | -$14.2M |
|
|
ITCI
5131
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.16M | ﹤0.01% |
39,900
-11,300
| -22% | -$546K |
|
5132
PUT
Progyny
PGNY
$2.01B
| $2.16M | ﹤0.01% |
67,200
+40,400
| +151% | +$1.33M |
|
5133
PUT
AerSale
ASLE
$278M
| $2.16M | ﹤0.01% |
125,300
-25,800
| -17% | -$459K |
|
5134
PUT
ProShares Ultra QQQ
QLD
$14.3B
| $2.16M | ﹤0.01% |
87,000
+30,400
| +54% | +$645K |
|
5135
CALL
Chefs' Warehouse
CHEF
$4.61B
| $2.16M | ﹤0.01% |
63,300
+4,000
| +7% | +$141K |
|
|
MREO
5136
Mereo BioPharma
MREO
$48.9M
| $2.15M | ﹤0.01% |
3,047,960
-14,372
| -0.5% | -$12.9K |
|
5137
CALL
Bankunited
BKU
$3.43B
| $2.15M | ﹤0.01% |
95,400
+94,200
| +7,850% | +$3.07M |
|
5138
CALL
Blue Owl Capital
OWL
$19.3B
| $2.15M | ﹤0.01% |
194,300
+51,000
| +36% | +$611K |
|
|
ICPT
5139
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.15M | ﹤0.01% |
159,959
-317,170
| -66% | -$5.49M |
|
|
XDJA
5140
DELISTED
Innovator U.S. Equity Accelerated ETF - January
XDJA
| $2.14M | ﹤0.01% |
100,313
-8,803
| -8% | -$183K |
|
5141
PUT
Build-A-Bear
BBW
$480M
| $2.14M | ﹤0.01% |
92,200
-43,300
| -32% | -$1.01M |
|
5142
MSCI
MSCI
$41.4B
| $2.14M | ﹤0.01% |
3,826
-170,818
| -98% | -$90.4M |
|
5143
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
$254M
| $2.14M | ﹤0.01% |
112,243
+78,000
| +228% | +$1.5M |
|
5144
CALL
Coursera
COUR
$1.53B
| $2.14M | ﹤0.01% |
185,800
-71,300
| -28% | -$923K |
|
5145
Precision BioSciences
DTIL
$200M
| $2.14M | ﹤0.01% |
94,580
+28,879
| +44% | +$952K |
|
5146
CALL
Community Health Systems
CYH
$423M
| $2.14M | ﹤0.01% |
436,000
+357,800
| +458% | +$1.88M |
|
5147
Luxfer Holdings
LXFR
$457M
| $2.14M | ﹤0.01% |
126,375
+7,396
| +6% | +$119K |
|
|
WHWK
5148
Whitehawk Therapeutics
WHWK
$256M
| $2.13M | ﹤0.01% |
294,793
-2,201
| -0.7% | -$23.5K |
|
5149
PUT
Tronox
TROX
$944M
| $2.13M | ﹤0.01% |
148,400
+99,300
| +202% | +$1.53M |
|
5150
PUT
Array Technologies
ARRY
$796M
| $2.13M | ﹤0.01% |
97,500
-50,900
| -34% | -$1.04M |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,467 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.